Corvex Management LP
Holdings History for GeneDx Holdings Corp. - Class A common stock, par value $0.0001 per share (WGS)
- Symbol
- WGS on Nasdaq
- Investment type
- Equity / Class A common stock, par value $0.0001 per share
Shares, Excluding Options vs Price
Value, Excluding Options
13F rows show quarter-end holdings reported by the manager. Values are filing-reported market values; price checks are local estimates.
| Holdings as of | Option type | Portfolio weight | Value change | SEC-reported value | Shares | Share change | Share activity | Price | All holders |
|---|---|---|---|---|---|---|---|---|---|
| 30 Jun 2026 | 10% | +3.3% | $328,460,731 | 4,784,570 | +1,556,421 | +48% | $68.65 | Q2 2026 | |
| 31 Mar 2026 | 8.2% | +0.43% | $207,311,729 | 3,228,149 | +169,520 | +5.5% | $64.22 | Q1 2026 | |
| 31 Dec 2025 | 13% | 0% | $397,805,288 | 3,058,629 | 0 | $130.06 | Q4 2025 | ||
| 30 Sep 2025 | 12% | 0% | $329,536,688 | 3,058,629 | 0 | $107.74 | Q3 2025 | ||
| 30 Jun 2025 | 12% | +2.3% | $282,342,043 | 3,058,629 | +584,848 | +24% | $92.31 | Q2 2025 | |
| 31 Mar 2025 | 8.5% | 0% | $219,090,414 | 2,473,781 | 0 | $88.56 | Q1 2025 | ||
| 31 Dec 2024 | 6.9% | 0% | $190,134,808 | 2,473,781 | 0 | $76.86 | Q4 2024 | ||
| 30 Sep 2024 | 4.3% | 0% | $104,987,266 | 2,473,781 | 0 | $42.44 | Q3 2024 | ||
| 30 Jun 2024 | 3.1% | 0% | $64,664,635 | 2,473,781 | 0 | $26.14 | Q2 2024 | ||
| 31 Mar 2024 | 1.1% | 0% | $22,585,621 | 2,473,781 | 0 | $9.13 | Q1 2024 | ||
| 31 Dec 2023 | 0.37% | -0.12% | $6,802,898 | 2,473,781 | -833,742 | -25% | $2.75 | Q4 2023 | |
| 30 Sep 2023 | 0.68% | 0% | $12,039,384 | 3,307,523 | 0 | $3.64 | Q3 2023 | ||
| 30 Jun 2023 | 1.1% | +1.1% | $19,712,837 | 3,307,523 | +3,307,523 | NEW | $5.96 | Q2 2023 |
SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held.
* marks a reported price that did not pass the local price check.
* marks a reported price that did not pass the local price check.